Literature DB >> 15573101

Cyclodextrin-based pharmaceutics: past, present and future.

Mark E Davis1, Marcus E Brewster.   

Abstract

Cyclodextrins are cyclic oligomers of glucose that can form water-soluble inclusion complexes with small molecules and portions of large compounds. These biocompatible, cyclic oligosaccharides do not elicit immune responses and have low toxicities in animals and humans. Cyclodextrins are used in pharmaceutical applications for numerous purposes, including improving the bioavailability of drugs. Current cyclodextrin-based therapeutics are described and possible future applications discussed. Cyclodextrin-containing polymers are reviewed and their use in drug delivery presented. Of specific interest is the use of cyclodextrin-containing polymers to provide unique capabilities for the delivery of nucleic acids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15573101     DOI: 10.1038/nrd1576

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  249 in total

1.  Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.

Authors:  Ketan Hippalgaonkar; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

2.  Assisting the reactivation of guanidine hydrochloride-denatured aminoacylase by hydroxypropyl cyclodextrins.

Authors:  Sung-Hye Kim; Jun Zhang; Yan Jiang; Hai-Meng Zhou; Yong-Bin Yan
Journal:  Biophys J       Date:  2006-04-21       Impact factor: 4.033

Review 3.  The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.

Authors:  Arik Dahan; Jonathan M Miller
Journal:  AAPS J       Date:  2012-03-06       Impact factor: 4.009

4.  Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.

Authors:  Manuel Haschke; Katja Suter; Sarah Hofmann; Robert Witschi; Johannes Fröhlich; Georgios Imanidis; Jürgen Drewe; Thomas A Briellmann; Franz E Dussy; Stephan Krähenbühl; Christian Surber
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

5.  Host-guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applications.

Authors:  Jianxiang Zhang; Peter X Ma
Journal:  Nano Today       Date:  2010-08-01       Impact factor: 20.722

Review 6.  Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease.

Authors:  Elizabeth A Ottinger; Mark L Kao; Nuria Carrillo-Carrasco; Nicole Yanjanin; Roopa Kanakatti Shankar; Marjo Janssen; Marcus Brewster; Ilona Scott; Xin Xu; Jim Cradock; Pramod Terse; Seameen J Dehdashti; Juan Marugan; Wei Zheng; Lili Portilla; Alan Hubbs; William J Pavan; John Heiss; Charles H Vite; Steven U Walkley; Daniel S Ory; Steven A Silber; Forbes D Porter; Christopher P Austin; John C McKew
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

7.  Modular multifunctional poly(ethylene glycol) hydrogels for stem cell differentiation.

Authors:  Anirudha Singh; Jianan Zhan; Zhaoyang Ye; Jennifer H Elisseeff
Journal:  Adv Funct Mater       Date:  2012-09-13       Impact factor: 18.808

8.  2-Hydroxypropyl-β-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy.

Authors:  Wensi Song; Fan Wang; Parisa Lotfi; Marco Sardiello; Laura Segatori
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

9.  Inhibition of anthrax protective antigen outside and inside the cell.

Authors:  Marina V Backer; Vimal Patel; Brian T Jehning; Kevin P Claffey; Vladimir A Karginov; Joseph M Backer
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

10.  Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy.

Authors:  Xiang Ling; Jiasheng Tu; Junqing Wang; Aram Shajii; Na Kong; Chan Feng; Ye Zhang; Mikyung Yu; Tian Xie; Zameer Bharwani; Bader M Aljaeid; Bingyang Shi; Wei Tao; Omid C Farokhzad
Journal:  ACS Nano       Date:  2018-12-04       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.